Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanfei Liu

Showing results (331-340 of 361) with videos related to

Pageof 37
Sort By:
Advanced Healthcare Materials|January 19, 2026
Antigen-Enriched Tumor-Dendritic Cell Fusion Membrane-Coated Metal-Phenolic Nanovaccine Enables Dual T-Cell Activation for Robust Cancer ImmunotherapyLishang Xu, Kan Shao, Yanfei Liu, et al.
Brain Imaging and Behavior|August 22, 2019
Altered amygdala resting-state functional connectivity following acupuncture stimulation at BaiHui (GV20) in first-episode drug-Naïve major depressive disorderGaoxiong Duan, Qianchao He, Yong Pang, et al.
Frontiers in Oncology|November 9, 2023
Management and clinical outcomes of follicular lymphoma across continuous lines of treatments: a retrospective analysis in ChinaJiaxin Liu, Yunfei Hu, Linjun Zhao, et al.
BMC Medicine|March 8, 2024
Camrelizumab plus gemcitabine and oxaliplatin for relapsed or refractory classical Hodgkin lymphoma: a phase II trialYanfei Liu, Lingyan Ping, Yuqin Song, et al.
Frontiers in Immunology|April 21, 2023
Antitumor activity and safety of camrelizumab combined with apatinib in patients with relapsed or refractory peripheral T-cell lymphoma: An open-label, multicenter, phase II studyYanfei Liu, Yuqin Song, Shubo Zuo, et al.
Free Radical Biology & Medicine|February 18, 2026
Corrigendum to "An intrabody targeting PHD2 protects mice against acetaminophen-induced liver injury by attenuating ferroptosis" [Free Radic. Biol. Med. 243 (2026) 260-275]Ze Ren, Ying Wang, Cheng Cheng, et al.
Medical Physics|January 10, 2025
Risk assessment and quality management in AIO based on CT-linac for nasopharyngeal carcinoma: An improved FMEA and FTA approachGuangyu Wang, Shouliang Ding, Xin Yang, et al.
Frontiers in Microbiology|December 9, 2022
The combination effect of meropenem/sulbactam/polymyxin-B on the pharmacodynamic parameters for mutant selection windows against carbapenem-resistant <i>Acinetobacter baumannii</i>Jiayuan Zhang, Shuo Diao, Yanfei Liu, et al.
Free Radical Biology & Medicine|November 24, 2025
An intrabody targeting PHD2 protects mice against acetaminophen-induced liver injury by attenuating ferroptosisZe Ren, Ying Wang, Cheng Cheng, et al.
International Journal of Colorectal Disease|June 26, 2023
The accuracy of the FIT in detecting advanced neoplasm is highest in young people aged 40 to 49 years: an analysis based on sex and ageKailong Zhao, Shuyuan Wang, Zhen Yuan, et al.
Pageof 37

Showing results (331-340 of 361) with videos related to

Sort By:
Pageof 37
Advanced Healthcare Materials|January 19, 2026
Antigen-Enriched Tumor-Dendritic Cell Fusion Membrane-Coated Metal-Phenolic Nanovaccine Enables Dual T-Cell Activation for Robust Cancer ImmunotherapyLishang Xu, Kan Shao, Yanfei Liu, et al.
Brain Imaging and Behavior|August 22, 2019
Altered amygdala resting-state functional connectivity following acupuncture stimulation at BaiHui (GV20) in first-episode drug-Naïve major depressive disorderGaoxiong Duan, Qianchao He, Yong Pang, et al.
Frontiers in Oncology|November 9, 2023
Management and clinical outcomes of follicular lymphoma across continuous lines of treatments: a retrospective analysis in ChinaJiaxin Liu, Yunfei Hu, Linjun Zhao, et al.
BMC Medicine|March 8, 2024
Camrelizumab plus gemcitabine and oxaliplatin for relapsed or refractory classical Hodgkin lymphoma: a phase II trialYanfei Liu, Lingyan Ping, Yuqin Song, et al.
Frontiers in Immunology|April 21, 2023
Antitumor activity and safety of camrelizumab combined with apatinib in patients with relapsed or refractory peripheral T-cell lymphoma: An open-label, multicenter, phase II studyYanfei Liu, Yuqin Song, Shubo Zuo, et al.
Free Radical Biology & Medicine|February 18, 2026
Corrigendum to "An intrabody targeting PHD2 protects mice against acetaminophen-induced liver injury by attenuating ferroptosis" [Free Radic. Biol. Med. 243 (2026) 260-275]Ze Ren, Ying Wang, Cheng Cheng, et al.
Medical Physics|January 10, 2025
Risk assessment and quality management in AIO based on CT-linac for nasopharyngeal carcinoma: An improved FMEA and FTA approachGuangyu Wang, Shouliang Ding, Xin Yang, et al.
Frontiers in Microbiology|December 9, 2022
The combination effect of meropenem/sulbactam/polymyxin-B on the pharmacodynamic parameters for mutant selection windows against carbapenem-resistant <i>Acinetobacter baumannii</i>Jiayuan Zhang, Shuo Diao, Yanfei Liu, et al.
Free Radical Biology & Medicine|November 24, 2025
An intrabody targeting PHD2 protects mice against acetaminophen-induced liver injury by attenuating ferroptosisZe Ren, Ying Wang, Cheng Cheng, et al.
International Journal of Colorectal Disease|June 26, 2023
The accuracy of the FIT in detecting advanced neoplasm is highest in young people aged 40 to 49 years: an analysis based on sex and ageKailong Zhao, Shuyuan Wang, Zhen Yuan, et al.
Pageof 37